{
    "title": "FDA halts use of antibody drugs that don't work vs. omicron",
    "url": "https://www.dailymail.co.uk/wires/ap/article-10437273/FDA-curbs-use-antibody-drugs-sidelined-omicron.html",
    "date": "2022-01-24",
    "keywords": [
        "omicron",
        "drug",
        "antibody",
        "health",
        "covid19",
        "variant",
        "fda",
        "use",
        "remdesivir",
        "government",
        "infusion",
        "move",
        "treatment",
        "supply",
        "disease",
        "decision",
        "desantis",
        "panel",
        "study",
        "science",
        "department",
        "washington",
        "regeneron",
        "work",
        "food",
        "administration",
        "emergency",
        "authorization",
        "action",
        "pushback",
        "advice",
        "resistance",
        "playbook",
        "battle",
        "pfizer",
        "merck",
        "glaxosmithkline",
        "death",
        "infection",
        "thenpresident",
        "donald",
        "trump",
        "combination",
        "coronavirus",
        "agency",
        "side",
        "december",
        "country",
        "distribution",
        "ron",
        "part",
        "response",
        "news",
        "vaccine",
        "gov",
        "greg",
        "abbott",
        "substitute",
        "vaccination",
        "heart",
        "approval",
        "risk",
        "hospital",
        "hospitalization",
        "institutes",
        "recommend",
        "effectiveness",
        "iv",
        "process",
        "wont",
        "option",
        "overcapacity",
        "staff",
        "reduction",
        "performance",
        "press",
        "support",
        "howard",
        "education",
        "ap",
        "content"
    ],
    "category": [
        "wires",
        "ap"
    ]
}